Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001193125-26-290622

Director sold 18,000 shares at $3.65 ($65,614)

From the SEC's structured data for this filing

Trades in this filing

Ezekowitz Alan · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-26 Sale : show line 1 in the form −18,000 $3.65 $65,614 10,927 D
Open-market sales · 18,000 sh · avg $3.65 · $65,614
Loading xslF345X06/ownership.xml…